Prostate Cancer Trial Results - National Cancer Institute
Links shared publicly online about this topic.
- 1,011total visits
Prostate Cancer Trial Results - National Cancer Institute
View full resource at cancer.gov
Tags: Cancer, Prostate Cancer, Prostate, Clinical Trial, Men's Health
Most Recently Shared on July 19, 2010 at 7:53 am By:
Prostate Cancer Trial Results - National Cancer Institute http://bit.ly/d4wsA0
Heart Disease May Be A Risk Factor For Prostate Cancer
medicalnewstoday.com — “In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, sug” View full resource at medicalnewstoday.com
Most Recently Shared on February 11, 2012 at 8:05 am By:
Heart Disease May Be A Risk Factor For Prostate Cancer http://t.co/hqrSNRHM #prostate
Heart disease may be a risk factor for prostate cancer
eurekalert.org — “In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.” View full resource at eurekalert.org
Most Recently Shared on February 8, 2012 at 3:46 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
Heart disease may be a risk factor for prostate cancer: ( Duke University Medical Center ) In a large analysis o... http://t.co/VQ4hPfMO
MedWire News - Gastroenterology - Repeat flexible sigmoidoscopy increases colorectal cancer detection rate
medwire-news.md — “MedWire News Repeat screening by flexible sigmoidoscopy after 3 to 5 years increases the detection of colorectal cancer or advanced adenoma by a quarter in women and by a third in men, show results of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. MedWire News” View full resource at medwire-news.md
Most Recently Shared on February 6, 2012 at 11:16 am By:
Repeat flexible sigmoidoscopy increases colorectal cancer detection rate http://t.co/TcwZ4yDn #oncology #colorectalcancer
In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival
medicalnewstoday.com — “A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular recept” View full resource at medicalnewstoday.com
Most Recently Shared on February 2, 2012 at 8:05 am By:
In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival http://t.co/rocDqfAo #prostate
Researchers target multiple tumors in new cancer vaccine study - FierceVaccines
fiercevaccines.com — “Targeting a variety of tumor types, the Roswell Park Cancer Institute has begun recruiting patients for an early-stage clinical trial to test an experimental cancer vaccine. The vaccine, or Read more...” View full resource at fiercevaccines.com
Most Recently Shared on January 26, 2012 at 2:06 pm By:
RT @FierceBiotech: Future threat to Provenge? New cancer vax study targets multiple tumors (prostate, lung, etc) http://t.co/oCAnW1wj
Soligenix reports results from orBec Phase 2 trial on acute GVHD
news-medical.net — “Soligenix, Inc., a development stage biopharmaceutical company, announced the publication of results from its investigator-initiated Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.” View full resource at news-medical.net
Most Recently Shared on December 12, 2011 at 3:10 pm By:
Prostate Cancer: Soligenix reports results from orBec Phase 2 trial on acute GVHD: Soligenix, Inc., a developmen... http://t.co/rU2LofNZ
Symposier - Healthy men taking vitamin E supplements have increased risk of developing prostate cancer
symposier.com — “Uploaded and shared in Youtube by: TheJAMAReport — Prior studies have shown a relationship between the supplements Selenium and Vitamin E and preventing prostate cancer. In 2008, researchers from the "SELECT" or Selenium and Vitamin E Cancer Prevention Trial found taking extra doses of these supplements did not help prevent the disease. Researchers then continued following the men even though they stopped taking the supplements. Long-term follow-up results show that men who took Vitami” View full resource at symposier.com
Most Recently Shared on December 7, 2011 at 5:26 am By:
Symposier Endocrino Health Site
Healthy men taking vitamin E supplements have increased risk of developing prostate cancer. http://t.co/RgWzxAsf
Denosumab and Bone-Metastasis-Free Survival In Men With Castration-Resistant Prostate Cancer: Results of a Phase 3, Randomised, Placebo-Controlled Trial - OncologySTAT
oncologystat.com — “Lancet. 2011 Nov 15;[Epub Ahead of Print] - MR Smith, F Saad, R Coleman, N Shore, C Goessl, et al” View full resource at oncologystat.com
Most Recently Shared on December 1, 2011 at 5:29 pm By:
OncologySTAT Health Site and Oncology
Story of the Week: Denosumab and Bone–Metastasis-Free Survival In Advanced Prostate Cancer http://t.co/SvZu9qdW
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial : The Lancet
thelancet.com — “Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. By - Prof Matthew R Smith MD, Prof Fred Saa...” View full resource at thelancet.com
Most Recently Shared on November 22, 2011 at 5:23 pm By:
Amgen's XGEVA delays onset of bone metastases in men with prostate cancer
news-medical.net — “Amgen announced today the publication of results from a Phase 3 trial (the '147 study) that evaluated XGEVA (denosumab) for use in preventing or delaying the onset of bone metastases in men with nonmetastatic castration-resistant prostate cancer.” View full resource at news-medical.net
Most Recently Shared on November 16, 2011 at 7:14 am By:
Amgen's XGEVA delays onset of bone metastases in men with prostate cancer: Amgen announced today the publication... http://t.co/VeFqFazS
Direct Injection Vaccine for Pancreas Cancer Associated with Stable Disease
newswise.com — “A series of vaccine injections given directly into a pancreatic cancer tumor is shown to be associated with stable disease. Early results of a clinical trial being conducted at The Cancer Institute of New Jersey are being presented on Tuesday at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics meeting being held in San Francisco.” View full resource at newswise.com
Most Recently Shared on November 12, 2011 at 7:37 pm By:
newswise Health Communicator and Health News
Direct Injection Vaccine for Pancreas Cancer Associated with Stable Disease: A series of vaccine injections give... http://t.co/CUD01C8i
Direct Injection Vaccine for Pancreas Cancer Associated with Stable Disease
newswise.com — “A series of vaccine injections given directly into a pancreatic cancer tumor is shown to be associated with stable disease. Early results of a clinical trial being conducted at The Cancer Institute of New Jersey are being presented on Tuesday at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics meeting being held in San Francisco.” View full resource at newswise.com
Most Recently Shared on November 12, 2011 at 6:51 pm By:
newswise Health Communicator and Health News
Direct Injection Vaccine for Pancreas Cancer Associated with Stable Disease: A series of vacc... http://t.co/ja8wgF33 | register to view
Teaching Hospitals Best For Prostate Cancer Surgery
medicalnewstoday.com — “Prostate cancer patients who undergo radical prostatectomy get better results at teaching hospitals than at non-academic medical institutions, according to the findings of an international study l” View full resource at medicalnewstoday.com
Most Recently Shared on November 9, 2011 at 8:05 am By:
Teaching Hospitals Best For Prostate Cancer Surgery http://t.co/gbw8b8wk #urology
Prostate cancer surgery better at teaching hospitals
medicalxpress.com — “Prostate cancer patients who undergo radical prostatectomy get better results at teaching hospitals than at non-academic medical institutions, according to the findings of an international study led by researchers at Henry Ford Hospital.” View full resource at medicalxpress.com
Most Recently Shared on November 7, 2011 at 3:53 pm By:
PhysOrg Health News Health News
Prostate cancer surgery better at teaching hospitals http://t.co/3djkuuVw
Phase 3 AFFIRM Trial Data of MDV3100 for Advanced Prostate Cancer - MPR
empr.com — “Medivation and Astellas announced positive results from an interim analysis of the Phase 3 AFFIRM trial of MDV3100 in men with advanced prostate cancer previously treated with chemotherapy.” View full resource at empr.com
Most Recently Shared on November 4, 2011 at 6:03 pm By:
Medivation Halts Phase 3 AFFIRM Trial of MDV3100 for Prostate Cancer Following Positive Results http://t.co/TLGyVoBH #ProstateCancer...
Advertisement
